Safety of 48 months of elagolix with add-back therapy for endometriosis-associated pain. [PDF]
AJOG Glob RepKim JH +5 more
europepmc +1 more source
Norethindrone Suppress the Germ Cell Development Via Androgen Receptor Resulting in Male Bias
, 2023 Wenjun Shi +7 more
openalex +1 more source
OP31.02: Changes in endometriomas and rectovaginal endometriotic nodules during treatment with norethindrone acetate or extended‐cycle oral contraceptive [PDF]
, 2017 Carolina Scala +5 more
openalex +1 more source
Bone mineral density with elagolix plus add-back therapy in women with heavy menstrual bleeding and uterine fibroids: open-label and post-treatment results of a 60-month phase 3 trial. [PDF]
AJOG Glob RepSchnell VL +6 more
europepmc +1 more source
Growth Stimulation and Differential Regulation of Transforming Growth Factor-β1 (TGFβ1), TGFβ2, and TGFβ3 Messenger RNA Levels by Norethindrone in MCF-7 Human Breast Cancer Cells [PDF]
, 1991 Meei‐Huey Jeng, V. Craig Jordan
openalex +1 more source
The Association Between Medroxyprogesterone Acetate Exposure and Cerebral Meningioma Among a Medicaid Population. [PDF]
Epidemiologia (Basel)Reynolds LM, Arend R, Griffin RL.
europepmc +1 more source
The Impact of Co-Exposure to Polystyrene Microplastics and the Progestin Norethindrone on Zebrafish
Shuhui Zhou +9 more
openalex +1 more source
Preoperative relugolix combination therapy in laparoscopic myomectomy: a case series evaluating impact on surgical planes and operative outcomes. [PDF]
Arch Gynecol ObstetVandermolen B +4 more
europepmc +1 more source
PHARMACOKINETIC STUDY OF NORETHINDRONE COPRECIPITATE [PDF]
, 1993 S. Abou-El-Ela, S. Safwat
openalex +1 more source